Ranhox-500
New Avenue For Angina Management

Composition : Ranolazine 500mg Extended Release

Form : Tablets / Pack : 1 X 10's / Type : AA

Description : The clinical efficacy, safety and tolerability of Ranolazine have been established in large clinical trials. Subgroup analyses have shown that patients with chronic angina appear to derive significant clinical and symptomatic benefit from ranolazine and possibly reductions in ischemia. Ranolazine appears to have other promising nonanginal effects, including glycemic control, improvements in endothelial function and decreases in the incidence of atrial fibrillation and other arrhythmias.Less than 2% of patients experience common side effects, the symptoms are mild, and they occur within the 1st few weeks of therapy - Texas Heart Institute Journal- 2010; 37(6): 641–647.

View more products with following salts